Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3710213013 | Granisetron-containing product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710214019 | Product containing granisetron in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Granisetron-containing product in transdermal dose form | Is a | Product containing granisetron (medicinal product) | true | Inferred relationship | Some | ||
| Granisetron-containing product in transdermal dose form | Is a | Product manufactured as transdermal dose form (product) | true | Inferred relationship | Some | ||
| Granisetron-containing product in transdermal dose form | Has active ingredient | Granisetron (substance) | true | Inferred relationship | Some | 1 | |
| Granisetron-containing product in transdermal dose form | Has manufactured dose form | Transdermal dose form (dose form) | true | Inferred relationship | Some | ||
| Granisetron-containing product in transdermal dose form | Plays role | Antiemetic therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) | Is a | False | Granisetron-containing product in transdermal dose form | Inferred relationship | Some | |
| Granisetron only product in transdermal dose form | Is a | True | Granisetron-containing product in transdermal dose form | Inferred relationship | Some |
Reference Sets
FHIR